Virbac SA engages in the manufacture and sale of veterinary medicines. The company is headquartered in Carros, Paca and currently employs 6,442 full-time employees. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus mainly on formulating drugs designed to prevent or cure certain animal diseases. Its product portfolio encompasses pet medications such as pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds and rodents, as well as livestock medications including pest control drugs and antibiotics intended for cattle, sheep, pigs and poultry. The company also offers food and electronic identification chips for pets.
최신 재무제표(Form-10K)에 따르면, Virbac SA의 총 자산은 $0이며, 순손실입니다.
VRBCF의 주요 재무 비율은 무엇인가요?
Virbac SA의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.
Virbac SA의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Virbac SA 주요 수익원은 Farm Animals - Other Ruminants이며, 최신 수익 발표에서 수익은 208,100,000입니다. 지역별로는 Europe (excluding France)이 Virbac SA의 주요 시장이며, 수익은 326,742,000입니다.